{"id":11776,"date":"2025-07-26T01:59:10","date_gmt":"2025-07-25T23:59:10","guid":{"rendered":"https:\/\/valintermed.com\/?p=11776"},"modified":"2025-07-26T01:59:10","modified_gmt":"2025-07-25T23:59:10","slug":"sindrom-kenni-keffi-tip-2","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-kenni-keffi-tip-2\/","title":{"rendered":"Kenny-Caffey syndrome type 2"},"content":{"rendered":"
<\/div>\n

Kenny-Caffey syndrome type 2 (KCS2) is a rare hereditary disorder characterized by a combination of hypoparathyroidism, osteoporosis, as well as decreased growth and multiple skeletal deformities. This syndrome is a consequence of a mutation in the gene encoding a protein responsible for the development and functioning of bone tissue. The pathology leads to disturbances in bone mineralization and growth, which causes a clinical picture that includes both systemic and local manifestations affecting not only the skeleton but also other organs. This syndrome was first described in 1968, and since then its genetic features and clinical manifestations have been identified, which allows for a more effective approach to its diagnosis and treatment.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n